3020-OL:HK:HK-X DBMSCIUSA (HKD)

COMMON STOCK | Other |

Last Closing

USD 1314

Change

0.00 (0.00)%

Market Cap

N/A

Volume

300.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

There is no Profile data available for 3020-OL.HK.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-28 )

Largest Industry Peers for Other

ETFs Containing 3020-OL:HK

DXZ:CA Dynamic Active U.S. Mid-C.. 11.35 % 0.87 %

N/A

CAD 0.03B
IHF iShares U.S. Healthcare P.. 7.69 % 0.43 %

N/A

N/A
TETF 6.19 % 0.64 %

N/A

N/A
BGU:CA Bristol Gate Concentrated.. 4.81 % 0.85 %

N/A

CAD 0.12B
IAI iShares U.S. Broker-Deale.. 4.70 % 0.42 %

N/A

N/A
WBIF WBI BullBear Value 3000 E.. 4.37 % 1.05 %

N/A

N/A
HDIV 2.83 % 0.00 %

N/A

N/A
RYH 1.72 % 0.40 %

N/A

N/A
DSTL Distillate US Fundamental.. 1.55 % 0.00 %

N/A

USD 2.05B
FSWD:LSE iShares Edge MSCI World M.. 1.50 % 0.00 %

N/A

N/A
IFSW:LSE iShares Edge MSCI World M.. 1.50 % 0.00 %

N/A

N/A
IBCZ:F iShares IV Public Limited.. 1.47 % 0.00 %

N/A

N/A
IS07:F iShares IV Public Limited.. 1.47 % 0.00 %

N/A

N/A
HONR 1.20 % 0.65 %

N/A

N/A
VVL:CA Vanguard Global Value Fac.. 0.66 % 0.40 %

N/A

N/A
SMD 0.45 % 0.10 %

N/A

N/A
ESGL ESGL Holdings Limited Ord.. 0.00 % 0.40 %

N/A

USD 0.08B
JKH 0.00 % 0.30 %

N/A

N/A
DRFU:CA Desjardins RI USA Multifa.. 0.00 % 0.57 %

N/A

CAD 5.97M
SPVM Invesco S&P 500 Value wit.. 0.00 % 0.39 %

N/A

USD 0.09B
RYF 0.00 % 0.40 %

N/A

N/A
XXM:CA 0.00 % 0.68 %

N/A

N/A
XMWD:LSE Xtrackers MSCI World Swap.. 0.00 % 0.00 %

N/A

N/A
IMCG iShares Morningstar Mid-C.. 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Other) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 21.78% 78% C+ 74% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 21.78% 78% C+ 74% C
Trailing 12 Months  
Capital Gain 34.22% 87% B+ 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 34.22% 87% B+ 79% B-
Trailing 5 Years  
Capital Gain 105.96% 87% B+ 82% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 105.96% 87% B+ 82% B
Average Annual (5 Year Horizon)  
Capital Gain 16.27% N/A N/A 79% B-
Dividend Return 16.27% N/A N/A 77% C+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 19.66% N/A N/A 72% C
Risk Adjusted Return 82.77% N/A N/A 98% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (HKD)

Quarterly Financials (HKD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike